Kailera Therapeutics Ownership | Who Owns Kailera Therapeutics?
Kailera Therapeutics Ownership Summary
Kailera Therapeutics is owned by 98.67% institutional investors, 8.88% insiders. Bain capital investors is the largest institutional shareholder, holding 22.26% of KLRA shares. Vanguard Health Care Inv is the top mutual fund, with 1.69% of its assets in Kailera Therapeutics shares.
KLRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kailera Therapeutics | 98.67% | 8.88% | -7.55% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital investors | 26.26M | 22.26% | $578.41M |
| Bain capital life sciences investors | 22.58M | 19.15% | $497.51M |
| Rtw investments, lp | 10.78M | 9.14% | $237.41M |
| Canada pension plan investment board | 7.30M | 6.19% | $160.92M |
| Atlas venture life science advisors | 5.17M | 5.06% | $59.06M |
| Fmr | 4.66M | 4.56% | $53.22M |
| Blackrock funding, inc. /de | 4.57M | 4.47% | $52.22M |
| Price t rowe associates inc /md/ | 3.53M | 3.00% | $77.86M |
| Citadel advisors | 3.24M | 2.75% | $71.39M |
| Adage capital partners gp | 3.21M | 2.72% | $70.68M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 22.58M | 29.58% | $497.51M |
| Royalty pharma sub-manager | 2.46M | 14.29% | $28.04M |
| Bain capital investors | 26.26M | 12.01% | $578.41M |
| Atlas venture life science advisors | 5.17M | 9.36% | $59.06M |
| Rtw investments, lp | 10.78M | 2.03% | $237.41M |
| Catalio capital management, lp | 468.75K | 1.94% | $10.33M |
| Cormorant asset management, lp | 550.00K | 0.62% | $12.12M |
| Siren | 2.21M | 0.60% | $25.29M |
| Frazier life sciences management | 1.10M | 0.53% | $24.23M |
| Vestal point capital, lp | 575.00K | 0.30% | $12.67M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bain capital investors | 26.26M | 12.01% | 26.26M |
| Bain capital life sciences investors | 22.58M | 29.58% | 22.58M |
| Rtw investments, lp | 10.78M | 2.03% | 10.78M |
| Canada pension plan investment board | 7.30M | 0.09% | 7.30M |
| Price t rowe associates inc /md/ | 3.53M | 0.01% | 3.53M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Eventide asset management | - | - | -616.72K |
| Ubs group | 469.58K | 0.00% | -503.10K |
| Sixth street partners management company | - | - | -362.91K |
| Td asset management | - | - | -147.70K |
| Manufacturers life insurance company, the | 81.81K | 0.00% | -68.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bain capital investors | 26.26M | 12.01% | 26.26M | $578.41M |
| Bain capital life sciences investors | 22.58M | 29.58% | 22.58M | $497.51M |
| Rtw investments, lp | 10.78M | 2.03% | 10.78M | $237.41M |
| Canada pension plan investment board | 7.30M | 0.09% | 7.30M | $160.92M |
| Price t rowe associates inc /md/ | 3.53M | 0.01% | 3.53M | $77.86M |
Sold Out
| Holder | Change |
|---|---|
| Fortitude family office | -32.00 |
| Persistent asset partners | -1.76K |
| Gabelli funds | -10.00K |
| Hudson bay capital management lp | -10.05K |
| Victory capital management | -10.31K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 100 | - | 116,376,860 | - | 98 | - | 100 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 2.19M | 1.69% | 2.19M |
| State Street® SPDR® S&P® Biotech ETF | 1.31M | 1.01% | 34.31K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.18M | 0.91% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.18M | 0.91% | - |
| iShares Russell 2000 ETF | 1.17M | 0.90% | - |
| Fidelity Growth Compy Commingled Pl S | 1.06M | 0.82% | 60.40K |
| Vanguard Small Cap Index | 835.57K | 0.64% | -17.72K |
| Columbia Small Cap Growth Inst | 784.06K | 0.60% | - |
| Fidelity Growth Company Fund | 700.90K | 0.54% | - |
| Columbia Small Cap Growth | 652.31K | 0.50% | 652.31K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 20, 2026 | RTW INVESTMENTS, LP | - | Buy | $8.00M |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC | - | Buy | $134.38M |
| Apr 20, 2026 | Koppel Adam | Buy | $25.00M | |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | - | Buy | $25.00M |
| Apr 20, 2026 | Kaplan Andrew T. | Buy | $134.38M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | 5 | - |
KLRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools